Methyldopa Waymade

Methyldopa, the active ingredient in Methyldopa Waymade, is a Alpha-2 adrenergic agonist presented as an oral tablet for oral use. It lowers blood pressure in adults with hypertension, including pregnancy‑induced hypertension.

GNH USA supplies Methyldopa Waymade as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methyldopa is an antihypertensive agent that acts on the central sympathetic nervous system to control elevated blood pressure. - Essential hypertension: reduces systolic and diastolic pressure in patients with primary hypertension. - Secondary hypertension: helps control blood pressure when caused by endocrine or renal disorders. - Pregnancy‑induced hypertension: provides a safer option for managing high blood pressure during pregnancy.

Methyldopa may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially when standing quickly. - Headache: mild to moderate pain often reported during initiation. - Fatigue: generalized tiredness that may affect daily activities. - Dry mouth: reduced salivation causing oral discomfort. - Nausea: upset stomach, sometimes with mild vomiting.

Serious or Rare Side Effects: - Hepatic dysfunction: elevated liver enzymes or jaundice requiring monitoring. - Hemolytic anemia: destruction of red blood cells leading to fatigue and pallor. - Severe hypotension: abrupt drop in blood pressure causing fainting. - Stevens‑Johnson syndrome: rare skin reaction with blistering and mucosal involvement. - Neuroleptic malignant‑like syndrome: rare but potentially life‑threatening condition with fever and muscle rigidity.

Methyldopa requires careful monitoring and patient education to minimize risks. - Blood pressure monitoring: check regularly to avoid excessive hypotension. - Liver function assessment: evaluate baseline enzymes and repeat if symptoms arise. - Depression screening: monitor for mood changes, as central alpha‑2 activation can affect neurotransmitters. - Cardiovascular disease caution: use cautiously in patients with coronary artery disease or heart failure. - Drug‑induced lupus watch: be alert for rash, arthralgia, or fever. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Methyldopa can alter the effects of several other medicines, requiring clinician oversight.

Major Interactions (Avoid): - MAO inhibitors: concurrent use may cause hypertensive crisis. - Direct-acting sympathomimetics (e.g., epinephrine): may blunt their pressor effect. - Antihypertensive combination therapy: risk of additive hypotension.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): may increase sedation. - Lithium: methyldopa can raise lithium levels, necessitating serum monitoring. - Antidiabetic agents: blood glucose may be affected, requiring glucose checks.